Clinically Effective A. Marginale Bovine Vaccine Makes International Research News, Causes Global Excitement for Cattle Ranchers Currently Battling Anaplasmosis Epidemic

‘For over 20 years now, our vaccine based on A. marginale rather than A. centrale has remained the best, most cost-effective protection in this ongoing battle against bovine anaplasmosis’ –Dr. Gene Luther, University Products LLC BATON ROUGE, La., June 1, 2022 /PRNewswire/ — University…

About the Author

has written 20742 stories on this site.

Copyright © 2010-2019 strategicbusinessnews.com